Timothy S. Cabral Sells 10,000 Shares of Doximity, Inc. (NASDAQ:DOCS) Stock

Doximity, Inc. (NASDAQ:DOCS - Get Free Report) Director Timothy S. Cabral sold 10,000 shares of the company's stock in a transaction on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director now owns 6,360 shares of the company's stock, valued at $381,600. This trade represents a 61.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Doximity Stock Performance

Shares of Doximity stock traded up $0.78 on Friday, reaching $61.19. 4,819,178 shares of the company were exchanged, compared to its average volume of 2,167,619. The firm has a market cap of $11.49 billion, a price-to-earnings ratio of 61.19, a P/E/G ratio of 4.10 and a beta of 1.33. Doximity, Inc. has a 1-year low of $25.00 and a 1-year high of $85.21. The company's 50-day moving average is $56.04 and its two-hundred day moving average is $58.68.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same period last year, the firm earned $0.25 EPS. Doximity's quarterly revenue was up 17.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of DOCS. Global Retirement Partners LLC raised its holdings in shares of Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after buying an additional 440 shares during the last quarter. VSM Wealth Advisory LLC bought a new position in Doximity in the 1st quarter worth approximately $29,000. Allworth Financial LP increased its position in Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after acquiring an additional 287 shares during the period. National Bank of Canada FI acquired a new position in Doximity during the 1st quarter worth $33,000. Finally, Spire Wealth Management increased its holdings in shares of Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DOCS has been the topic of a number of recent analyst reports. William Blair reiterated an "outperform" rating on shares of Doximity in a report on Friday, May 16th. Mizuho reduced their price target on Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a report on Friday, May 16th. BTIG Research upgraded Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price objective for the company in a research note on Monday, June 2nd. Robert W. Baird cut their target price on Doximity from $87.00 to $65.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Finally, Morgan Stanley dropped their price target on shares of Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research note on Thursday, April 24th. Eleven research analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $63.11.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.